University of Ioannina
Έλεγχος λανθάνουσας φυματίωσης με την ταυτόχρονη διενέργεια φυματινοαντίδρασης και δοκιμασίας προσδιορισμού ιντερφερόνης-γ σε πληθυσμιακές ομάδες με αυξημένο κίνδυνο ανάπτυξης TBC
Abstract
dc:descriptionTuberculosis (TB) remains one of the most fatal infectious diseases worldwide, accounting for more than 2 million deaths annually. One-third of the world’s population is infected with Mycobacterium tuberculosis while World Health Organization estimates a prevalence of 19 new cases/ 100 000/ year in Greece, among the highest in Western Europe. A critical step in the elimination of tuberculosis would be the prompt diagnosis of latent tuberculosis. For more than a century and until recently, Mantoux has been the only method for the assessment of infection with the Mycobacterium of tuberculosis. The above technique has some drawbacks, the most important of which is the occurrence of false positive results due to infection with non-tuberculous mycobacteria or after the vaccination with BCG that has as a result the application of unnecessary treatment. A major breakthrough in recent years has been the development of new techniques, called interferon-γ release assays. With the above techniques, T cell release of interferon- γ in response to stimulation to antigens specific for the Mycobacterium of tuberculosis, is measured. Two assays have become commercially available: QuantiFERON – TB Gold assay and T-SPOT. TB. A major challenge is the prompt diagnosis and treatment of tuberculosis in the elderly who are at increased risk of incurring TBC reactivation due to the impairment of cell immunity and the co-existence of acute or chronic diseases. In Greece, a large percentage of geriatric population lives in nursing homes. There have been only a few studies investigating the effect of contact with people suffering from active tuberculosis in such settings while there are no explicit and unified recommendations in regard policies and practices of TB screening among elderly residents and staff working in nursing homes. In Greece there have been no studies comparing the efficacy of interferon-γ release assays and Mantoux in BCG vaccinated populations and estimating the value of IGRA in the diagnosis of latent tuberculosis in the elderly. The aim of the first phase of the present study is to compare Mantoux and the interferon-γ release assays, in particular Quantiferon TB Gold in tube assay, in Greek Army recruits that have been vaccinated with BCG in their childhood and had not been exposed to tuberculosis in the past. We also studied the effect on TST of the interval since BCG vaccination. Of 56368 subjects who enlisted at all recruitment centers throughout Greece 1765 were enrolled in our study. We excluded 15 recruits with chronic medical conditions, because of receiving treatment for either active or latent tuberculosis, and due recent exposure to patients suffering from active tuberculosis. A total number of 1750 recruits were finally enrolled in our study. Of a total of 1750 subject 96 (5.4%) were TST-positive with an induration size ≥ 10 mm. The 111 participants with TST≥0 mm were divided in four groups according to the defined TST grouping values. The first group included subjects with TST induration 1-4 mm the second group with TST 5-9mm, the third group with 10-14mm and the fourth included recruits with ≥ 15 mm. From the participants, one subject (0.9%) had an induration size of 1-4 mm, 14 subjects (12.6%) had a TST result of 5-9 mm, 37 subjects (33.3%) had an induration size of 10-14 mm and 59 recruits (53.2%) had a TST result of ≥15 mm. 1639 (93.7%) recruits had a TST of 0 mm. For reasons of functionality, only a subgroup of 18 subjects with a TST of 0 mm was selected through randomization to constitute a negative-control group. Positive QFT-GIT results were observed in 11 of the 96 recruits who were positive by TST (11.4%) while there were no indeterminate results. When we grouped the recruits according to TST results, we found that among recruits with TST:1-9 mm 1 out of 14 was positive by QFT-GIT, among those with TST:10-14 mm QFT-GIT was negative in all of them (0/36 subjects), and among those with TST ≥15 mm QFT-GIT was positive in 11/57. One out of 18 negative-control subjects with TST result of 0 mm was positive by QFT-GIT. At the study of the effect on TST of the interval since BCG vaccination, no statistical significance was found between the group vaccinated 9-14 years before and the group vaccinated 15-29 years before suggesting that the effect of BCG on TST is long lasting. Our study demonstrated a significant discordance between Mantoux and interferon-γ release assays. We excluded other potential causes of the discordance between the two methods, such as exposure to non tuberculous mycobacteria or low IGRA sensitivity due to false negative results demonstrating the effect of BCG on TST and the fact that the results of interferon-γ release assays remain unaffected. Based on the fact that vaccination with BCG in Greece is mandatory and received at the age of six years old, when BCG effect on TST is substantial, a two-step approach to identify young adults with LTBI seems to be more reliable. All BCG vaccinated young adults should be screened with TST and those with TST indurations of 10 mm or more should undergo an IGRA test. Only those with positive IGRA results should be treated for LTBI in order to avoid treatment side effects, economical and psychological burden, due to an unnecessary treatment. The aim of the second phase of the present study was to assess the additive value of a newly marketed interferon-γ release assay, QuantiFERON-TB Gold In-Tube (QFT-GIT), to the tuberculin skin test (TST) for the detection of latent tuberculosis infection (LTBI) among elderly TB contacts in a nursing home. A total of 77 individuals participated in this study. The participants were in continuous contact with the infected resident of the nursing home and specifically they were exposed to the index case for more than 40 hours prior to the diagnosis. They were divided into two groups. Group A consisted of 63 elderly people, residents of the nursing home with mean age 82 ± 10 years old while Group B consisted of 14 younger employees with mean age 41.2 ± 9.2 years old. All these contacts underwent TST more than 2 months after their first exposure to the case. According to the induration size of TST the two groups were subdivided in two subgroups. The subgroup 1 consisted of the participants with positive TST results and the subgroup 2 of those with negative TST results. According to American Thoracic Society positive TST values of ≥ 5mm were judged positive as estimated by using the ballpoint pen-ruler method. Contacts with negative TST (<5mm) were evaluated with QFT-GIT. The QFT-GIT was performed at the day of TST reading that is after 72 hours after TST performing. 20/63 (31.7%) of the elderly residents had positive TST (≥ 5mm) compared to 6/14 (43%) of young employees with mean induration size of 5.5 ± 9.3 mm και 5.8 ± 7.9 mm respectively. All of them were treated for LTBI after 13 4 meticulous examination to exclude active TB. Positive QFT-GIT results were observed in 7/43 (16.3%) of the elderly residents with negative TST increasing the percentage of individuals with possible LTBI from 31.7% regarding positive TST to 42.9% regarding either positive TST or IGRA. The rate of positive QFT-GIT in those under 80 years old was 14% (1/7) which amounted to 86% (6/7) in those over 80 years old. The results of this study show that interferon-γ release assays demonstrate an additive value in detecting LTBI in subjects that present anergy with TST method. The present study revealed seven subjects with negative TST results but positive IGRA results increasing the percentage of latent tuberculosis from 31.7% to 42.9%. If the interferon-γ release assays have not been used there would be no diagnosis of latent tuberculosis in these seven subjects or the diagnosis would be delayed pending the results of the second Mantoux, according to the two steps procedure. Another interesting finding of our study was that QFT-GIT results were negative in TST negative elderly contacts with fibrotic-appearing lesions on their chest radiographs. These subjects would have received “preventive” therapy, according to ATS guidelines concerning groups of individuals at greater risk of tuberculosis. However, IGRA obviated the need of LTBI treatment in those elderly individuals prone to side effects of treatment since negative results were observed. The simultaneous use of interferon-γ release assays and Mantoux for the detection of LTBI among elderly individuals in contact with an active TBC contact seem to be most reliable and faster practice than two step Mantoux implementation. The above practice along with the development of prevention policies will lead to the decrease of tuberculosis incidence in nursing homes.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Νικολοπούλου, Μαρία-Μελίτα
- Nikolopoulou, Melita
Subjects
dc:subject × 14- Φυματίωση, Λανθάνουσα
- Φυματινοαντίδραση Mantoux
- Δοκιμασία QuantiFERON-TB Gold - In Tube
- Εμβολιασμένοι με BCG
- Ηλικιωμένοι
- Latent tuberculosis infection
- Mantoux method
- Interferon - γ release assay (QFT - GIT)
- BCG vaccinated
- Elderly
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26950